Unichem Labs gets USFDA approval for Amitriptyline HCL Tablets

Amitriptyline HCL Tablets are indicated for the relief of symptoms of depression.

63
Medicine
Picture: Pixabay

Unichem Laboratories has received ANDA approval for its Amitriptyline HCL Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg from the United States Food and Drug Administration (USFDA)

The drug is to market a generic version of ELAVIL (Amitriptyline Hydrochloride) 10 mg, 25 mg, 50 mg, 75 mg, 100 mg and 150 mg of AstraZeneca Pharmaceuticals LP.

Amitriptyline HCL Tablets are indicated for the relief of symptoms of depression.

The product will be commercialised from Unichem’s Goa Plant.


Also read other approvals:

Alembic gets USFDA Final nod for Lurasidone HCL Tablets

Alembic gets USFDA nod for depression treatment drug

Caplin gets USFDA nod for Neostigmine Methylsulfate Injection

Gilead gets USFDA nod to treat metastatic urothelial cancer

NATCO gets tentative USFDA nod for Ibrutinib tablets

First AI device to help detect colon cancer gets USFDA nod


Also read:

NPPA fixes retail prices of 2 formulations

Bring Nutraceuticals for prevention of diseases under DCGI’s regulation: Experts to…

Baricitinib: BDR Pharma signs licensing agreement with Lilly

Optimus Pharma gets DCGI nod for Phase III trials of Molnupiravir

Black Fungus: AIIMS to develop Guidelines for treatment

NPPA directs Pulse Oximeter & Oxygen Concentrators to submit MRP

Subscribe for daily free updates on Telegram

Follow us on Facebook and Linkedin

For daily free updates on WhatsApp, click here

Enter your email address:

Delivered by FeedBurner